Mobile Technologies Extending Reach of Primary Care for Substance Use Disorders

Summary

The goal of this clinical trial is to evaluate efficacy of our enhanced version of the CHESS Health eIntervention in a clinical setting for those with moderate risk drug or alcohol use and those at high risk or with Substance Use Disorder (SUD) as measured by the ASSIST and the AUDIT assessment tools. The clinical trial is designed to determine whether SBIRT/eIntervention is significantly more effective than SBIRT/Treatment as usual (TAU) as delivered in a primary care setting. While it is not feasible or practical to individually test all components and features of the planned eIntervention, this design will permit testing of efficacy for reduction of substance use in both risk groups and increased enrollment in treatment for the high risk/SUD group in the SBIRT/eIntervention cohorts compared to the SBIRT/TAU cohorts. Note that the investigators are not including a screening/assessment only or other control condition, as the purpose of this clinical trial is not to test the efficacy of SBIRT itself, but rather to test whether SBIRT/eIntervention improves outcomes and successful referral relative to SBIRT/TAU delivery alone.

Conditions

• Substance-Related Disorders

Interventions

DEVICE

SBIRT/eIntervention for those with moderate risk drug or alcohol use

The Connections App is available on iOS or Android and will be offered to the patient during the referral process and contains the following functionalities: * Online view of the referrals made for them e.g. to healthcare provider * Secure messaging with the referring provider * Secure messaging with the destination provider(s) to support them to adhere to the referral, and/or the patient can seek assistance with the destination provider, * Informative multimedia content filtered from a library to fit the patient including testimonial content from peers thus showing the patient that others like them have shared their addiction experience and successfully received treatment and achieved recovery, * Capture structured feedback from the patient The patient may access more functionality within the Connections App for those who wish to modify behavior using eTherapy and eRecovery. eRecovery includes ecological momentary assessments (EMA) selected by the provider.

DEVICE

SBIRT/eIntervention those assessed with high risk.

The Connections App is available on iOS or Android and will be offered to the patient during the referral process and contains the following functionalities: * Online view of the referrals made for them e.g. to healthcare provider * Secure messaging with the referring provider * Secure messaging with the destination provider(s) to support them to adhere to the referral, and/or the patient can seek assistance with the destination provider, * Informative multimedia content filtered from a library to fit the patient including testimonial content from peers thus showing the patient that others like them have shared their addiction experience and successfully received treatment and achieved recovery, * Capture structured feedback from the patient The patient may access more functionality within the Connections App for those who wish to modify behavior using eTherapy and eRecovery. eRecovery includes ecological momentary assessments (EMA) selected by the provider.

OTHER

SBIRT/TAU for those with moderate risk drug or alcohol use

Treatment as usual

OTHER

SBIRT/TAU for those assessed with high risk.

Treatment as usual for high risk group

Sponsors & Collaborators

• Western Michigan University

  collaborator OTHER

• National Institute on Drug Abuse (NIDA)

  collaborator NIH

• Chess Mobile Health

  lead INDUSTRY

Principal Investigators

• Hans Morefield · CHESS Health

Study Design

Allocation

RANDOMIZED

Purpose

SCREENING

Masking

NONE

Model

PARALLEL

Eligibility

Min Age

18 Years

Sex

ALL

Healthy Volunteers

No

Timeline & Regulatory

Start

2024-03-25

Primary Completion

2026-02-26

Completion

2026-02-26

Countries

• United States

Study Locations